RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
BARD1 Life Sciences Stock

BARD1 Life Sciences Dividend 2024

BARD1 Life Sciences Dividend

0 AUD

BARD1 Life Sciences Dividend yield

Ticker

BD1.AX

ISIN

AU000000BD12

WKN

A2AL50

How much dividend does BARD1 Life Sciences 2024 pay?

According to the latest status from September 2024, BARD1 Life Sciences paid a total of 0 AUD per share in dividends within the last 12 months. With the current BARD1 Life Sciences price of 1.03 AUD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical BARD1 Life Sciences Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the BARD1 Life Sciences Dividend Safe?

BARD1 Life Sciences has been increasing the dividend for 0 years.

Over the past 10 years, BARD1 Life Sciences has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding BARD1 Life Sciences's Dividend Distributions

BARD1 Life Sciences’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining BARD1 Life Sciences's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

BARD1 Life Sciences's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in BARD1 Life Sciences’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

BARD1 Life Sciences Aktienanalyse

What does BARD1 Life Sciences do?

BARD1 Life Sciences Ltd. is an Australian biotechnology company specializing in the development of diagnostics and therapeutics for cancer. The company was founded in 1999 and is headquartered in Sydney. BARD1 Life Sciences is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about BARD1 Life Sciences stock

How much dividend does BARD1 Life Sciences pay?

Over the past 12 months, BARD1 Life Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BARD1 Life Sciences is expected to pay a dividend of 0 AUD.

What is the dividend yield of BARD1 Life Sciences?

The current dividend yield of BARD1 Life Sciences is .

When does BARD1 Life Sciences pay dividends?

BARD1 Life Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of BARD1 Life Sciences?

BARD1 Life Sciences paid dividends every year for the past 0 years.

What is the dividend of BARD1 Life Sciences?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is BARD1 Life Sciences located?

BARD1 Life Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von BARD1 Life Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of BARD1 Life Sciences from 9/16/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/16/2024.

When did BARD1 Life Sciences pay the last dividend?

The last dividend was paid out on 9/16/2024.

What was the dividend of BARD1 Life Sciences in the year 2023?

In the year 2023, BARD1 Life Sciences distributed 0 AUD as dividends.

In which currency does BARD1 Life Sciences pay out the dividend?

The dividends of BARD1 Life Sciences are distributed in AUD.

Andere Kennzahlen von BARD1 Life Sciences

Our stock analysis for BARD1 Life Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BARD1 Life Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.